tetano
Editor, Senior Moderator
Cureus
. 2023 Jan 18;15(1):e33952.
doi: 10.7759/cureus.33952. eCollection 2023 Jan.
Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
Lanka Wijekoon[SUP] 1 [/SUP], Chamara Sarathchandra[SUP] 1 [/SUP], Sisira Siribaddana[SUP] 1 [/SUP]
Affiliations
Abstract
We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first BBIBP-CorV vaccine. A bifacial palsy with a paresthesia variant of GBS was diagnosed, and the patient was treated with intravenous immunoglobulin, arresting the progression of neurological symptoms. Clinicians need to be aware of the possibility of GBS following vaccination with BBIBP-CorV, an inactivated SARS-CoV-2 vaccine.
Keywords: bifacial weakness with paraesthesia; covid-19 vaccine complication; guillain barre syndrome (gbs); nerve conduction studies (ncs); sinopharm bbibp.
. 2023 Jan 18;15(1):e33952.
doi: 10.7759/cureus.33952. eCollection 2023 Jan.
Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV
Lanka Wijekoon[SUP] 1 [/SUP], Chamara Sarathchandra[SUP] 1 [/SUP], Sisira Siribaddana[SUP] 1 [/SUP]
Affiliations
- PMID: 36819409
- PMCID: PMC9937680
- DOI: 10.7759/cureus.33952
Abstract
We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first BBIBP-CorV vaccine. A bifacial palsy with a paresthesia variant of GBS was diagnosed, and the patient was treated with intravenous immunoglobulin, arresting the progression of neurological symptoms. Clinicians need to be aware of the possibility of GBS following vaccination with BBIBP-CorV, an inactivated SARS-CoV-2 vaccine.
Keywords: bifacial weakness with paraesthesia; covid-19 vaccine complication; guillain barre syndrome (gbs); nerve conduction studies (ncs); sinopharm bbibp.